vs
Side-by-side financial comparison of New Fortress Energy Inc. (NFE) and Bio-Techne (TECH). Click either name above to swap in a different company.
New Fortress Energy Inc. is the larger business by last-quarter revenue ($326.2M vs $295.9M, roughly 1.1× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -259.7%, a 272.5% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -7.0%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -26.8%).
New Fortress Energy Inc. is a global energy infrastructure firm developing, owning and operating LNG import/export terminals, natural gas supply networks and low-carbon projects. It serves utility, industrial and public sector clients across the Americas and Caribbean, delivering affordable, lower-emission energy resources.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
NFE vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $326.2M | $295.9M |
| Net Profit | $-847.1M | $38.0M |
| Gross Margin | 35.5% | 64.6% |
| Operating Margin | -193.0% | 18.4% |
| Net Margin | -259.7% | 12.8% |
| Revenue YoY | -7.0% | -6.4% |
| Net Profit YoY | -277.4% | 68.3% |
| EPS (diluted) | $-3.03 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $326.2M | $295.9M | ||
| Q3 25 | $240.3M | — | ||
| Q2 25 | $228.1M | $317.0M | ||
| Q1 25 | $384.9M | $316.2M | ||
| Q4 24 | $350.7M | $297.0M | ||
| Q3 24 | $446.0M | $289.5M | ||
| Q2 24 | $291.2M | $306.1M | ||
| Q1 24 | $609.5M | $303.4M |
| Q4 25 | $-847.1M | $38.0M | ||
| Q3 25 | $-263.0M | — | ||
| Q2 25 | $-546.5M | $-17.7M | ||
| Q1 25 | $-175.4M | $22.6M | ||
| Q4 24 | $-224.4M | $34.9M | ||
| Q3 24 | $9.3M | $33.6M | ||
| Q2 24 | $-88.9M | $40.6M | ||
| Q1 24 | $54.1M | $49.1M |
| Q4 25 | 35.5% | 64.6% | ||
| Q3 25 | 18.1% | — | ||
| Q2 25 | 8.4% | 62.7% | ||
| Q1 25 | 21.4% | 67.9% | ||
| Q4 24 | 17.6% | 65.3% | ||
| Q3 24 | 27.1% | 63.2% | ||
| Q2 24 | 23.8% | 66.4% | ||
| Q1 24 | 62.4% | 67.4% |
| Q4 25 | -193.0% | 18.4% | ||
| Q3 25 | -37.4% | — | ||
| Q2 25 | -170.3% | -7.5% | ||
| Q1 25 | -3.3% | 12.2% | ||
| Q4 24 | 65.0% | 16.0% | ||
| Q3 24 | 17.8% | 13.8% | ||
| Q2 24 | 12.3% | 15.0% | ||
| Q1 24 | 30.4% | 22.1% |
| Q4 25 | -259.7% | 12.8% | ||
| Q3 25 | -109.4% | — | ||
| Q2 25 | -239.6% | -5.6% | ||
| Q1 25 | -45.6% | 7.1% | ||
| Q4 24 | -64.0% | 11.7% | ||
| Q3 24 | 2.1% | 11.6% | ||
| Q2 24 | -30.5% | 13.3% | ||
| Q1 24 | 8.9% | 16.2% |
| Q4 25 | $-3.03 | $0.24 | ||
| Q3 25 | $-0.96 | — | ||
| Q2 25 | $-1.99 | $-0.11 | ||
| Q1 25 | $-0.65 | $0.14 | ||
| Q4 24 | $-1.10 | $0.22 | ||
| Q3 24 | $0.03 | $0.21 | ||
| Q2 24 | $-0.42 | $0.26 | ||
| Q1 24 | $0.23 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $226.5M | $172.9M |
| Total DebtLower is stronger | $8.2B | $260.0M |
| Stockholders' EquityBook value | $182.6M | $2.0B |
| Total Assets | $10.6B | $2.5B |
| Debt / EquityLower = less leverage | 44.78× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $226.5M | $172.9M | ||
| Q3 25 | $145.2M | — | ||
| Q2 25 | $551.1M | $162.2M | ||
| Q1 25 | $447.9M | $140.7M | ||
| Q4 24 | $492.9M | $177.5M | ||
| Q3 24 | $90.8M | $187.5M | ||
| Q2 24 | $133.0M | $152.9M | ||
| Q1 24 | $143.5M | $145.3M |
| Q4 25 | $8.2B | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $8.9B | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $182.6M | $2.0B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.8B | $2.0B | ||
| Q4 24 | $1.9B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.6B | $2.1B | ||
| Q1 24 | $1.7B | $2.0B |
| Q4 25 | $10.6B | $2.5B | ||
| Q3 25 | $12.0B | — | ||
| Q2 25 | $12.0B | $2.6B | ||
| Q1 25 | $13.1B | $2.6B | ||
| Q4 24 | $12.9B | $2.7B | ||
| Q3 24 | $12.0B | $2.7B | ||
| Q2 24 | $11.4B | $2.7B | ||
| Q1 24 | $10.9B | $2.7B |
| Q4 25 | 44.78× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 4.74× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-76.2M | — |
| Free Cash FlowOCF − Capex | $-134.8M | — |
| FCF MarginFCF / Revenue | -41.3% | — |
| Capex IntensityCapex / Revenue | 18.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.4B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-76.2M | — | ||
| Q3 25 | $-171.0M | — | ||
| Q2 25 | $-329.0M | $98.2M | ||
| Q1 25 | $-7.2M | $41.1M | ||
| Q4 24 | $445.3M | $84.3M | ||
| Q3 24 | $-20.0M | $63.9M | ||
| Q2 24 | $113.9M | $75.5M | ||
| Q1 24 | $63.0M | $81.0M |
| Q4 25 | $-134.8M | — | ||
| Q3 25 | $-231.6M | — | ||
| Q2 25 | $-726.7M | $93.3M | ||
| Q1 25 | $-262.3M | $31.0M | ||
| Q4 24 | $-210.3M | $77.5M | ||
| Q3 24 | $-367.0M | $54.7M | ||
| Q2 24 | $-493.2M | $57.5M | ||
| Q1 24 | $-457.9M | $64.5M |
| Q4 25 | -41.3% | — | ||
| Q3 25 | -96.4% | — | ||
| Q2 25 | -318.6% | 29.4% | ||
| Q1 25 | -68.2% | 9.8% | ||
| Q4 24 | -60.0% | 26.1% | ||
| Q3 24 | -82.3% | 18.9% | ||
| Q2 24 | -169.3% | 18.8% | ||
| Q1 24 | -75.1% | 21.3% |
| Q4 25 | 18.0% | — | ||
| Q3 25 | 25.2% | — | ||
| Q2 25 | 174.4% | 1.5% | ||
| Q1 25 | 66.3% | 3.2% | ||
| Q4 24 | 187.0% | 2.3% | ||
| Q3 24 | 77.8% | 3.2% | ||
| Q2 24 | 208.4% | 5.9% | ||
| Q1 24 | 85.5% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | -2.15× | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | 1.16× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NFE
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
